
The device is approved for commercial use in more than 50 countries but is limited to investigational use in the United States and Japan.

The device is approved for commercial use in more than 50 countries but is limited to investigational use in the United States and Japan.

Researchers note that efforts are needed to align clinical practice with clinical guidelines.

Weight from age 25 onwards has been linked to the risk of more or less heart damage, as measured by levels of the protein troponin, underscoring the importance of long-term weight control.

More potent than hydrochlorothiazide to treat hypertension, this non-thiazide diuretic deserves a closer look.

Chlorthalidone is one of the "Rodney Dangerfield" diuretics in the treatment of hypertension. That needs to change.

This 83-year-old man is treated only for hypertension and says he "feels like Tarzan." The routine ECG says otherwise.

Click through this short case study for an illustration of the key principles put forth in the revised ACC/AHA guidelines on hypertension diagnosis and management.





T or F: A delayed decline of SBP during exercise recovery predicts severe coronary artery disease. Try the rest of this exercise challenge.

Tablets are approved in several dose types

Are fixed-dose antihypertensives here to stay? How does the newest combination work? Try this spot-check quiz.

Break out the blue paint for women with higher preconception blood pressure.

Maryland researchers found that even mild hypoglycemia can pose a cardiovascular risk in obese people with diabetes.

In just over a year, Praluent has shown benefits in helping patients lower their cholesterol level. Despite the progress, there have also been some challenges.

There are a lot of tasty things that people with diabetes should not eat. But butter is not one of them, a study found.

For many years, there were no good treatments for patients with pulmonary hypertension. That has changed recently, but there is still much more work to be done.

Unlike other conditions, pulmonary hypertension has symptoms that can be hard to identify in order to give the patients the right diagnosis. Misdiagnosis can not only worsen the symptoms, but also make treatment that much harder in the long run.

Phase 3 trials showed that empaglifloxin (Jardiance/Boehringer Ingelheim and Lilly) can reduce blood pressure in type 2 patients.

Acupuncture has been used and studied as an alternative pain management method, and although it appears to offer some benefit as a treatment for some forms of chronic pain, the evidence supporting its positive effect on other health conditions is uneven at best.

Controlling blood pressure may be more important in stroke prevention in patients with non-valvular atrial fibrillation than thought.

For many, cardiovascular disease can be seen as mostly an issue facing men. However, work has been done to raise the education of women to help ensure their health as well.

One nephrologist's thoughts on where in the annals of hypertension trials the SPRINT results may settle.